Altaire Recalls Ortho-K Gel Due to Sterility Assurance Concerns
Altaire Pharmaceuticals is recalling Natural Ophthalmics Ortho-K Thick Comfort Gel because the company cannot ensure the product is sterile.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classified this as an FDA Class II recall. Per the rubric, FDA Class II recalls are assigned a severity score of 4 (Severe), particularly given the risk of infection associated with lack of sterility assurance in ophthalmic products.
Plain-English summary
Altaire Pharmaceuticals, Inc. is recalling Natural Ophthalmics Ortho-K Thick Comfort Gel, 15 mL (NDC 68770-143-15). The recall is being conducted because the company lacks assurance of the product's sterility.
The recall involves 81,969 units distributed nationwide in the United States. The affected product codes are 17210 (expiration 7/19), 17378 (expiration 12/19), and 18175 (expiration 7/20).
Consumers should stop using the product and contact Altaire Pharmaceuticals for further instructions or a refund.
The recalled product
- Product
- Natural Ophthalmics Ortho-K Thick Comfort Gel, 15 mL, NDC 68770-143-15
- Manufacturer
- Altaire Pharmaceuticals, Inc.
- Category
- Drug — Ophthalmic
- Hazard
- Affected units
- 81,969
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- 17210 7/19 17378 12/19 18175 7/20
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 134 recalled by Altaire Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 134 products in this recall →Related recalls
Same manufacturer · Altaire Pharmaceuticals, Inc.
See all →- SevereCVS Health Dry Eye Relief Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2019-11-27
- SevereCVS Health Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2019-11-27
- SevereCVS Health Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2019-11-27
- SevereAltaire Recalls Equate Support Advanced Twin Pack Due to Sterility Concerns
FDA (Drugs) · 2019-11-27
- SevereAltaire Recalls OCuSOFT Ophthalmic Ointment Due to Sterility Concerns
FDA (Drugs) · 2019-11-27
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- SevereBella Pharmaceuticals Recalls Lidocaine Ophthalmic Gel Due to Sterility Concerns
FDA (Drugs) · 2017-09-20
- SevereClinical Specialties Compounding Pharmacy Recalls Ophthalmic Dilation Gel
FDA (Drugs) · 2013-07-10
- SevereRed Mountain Compounding Recalls Ophthalmic Gel Due to Sterility Concerns
FDA (Drugs) · 2019-11-13
- SevereKetorolac Tromethamine Ophthalmic Solution Recalled for Sterility Risk
FDA (Drugs) · 2025-07-02
- SevereCarboxymethylcellulose Sodium Ophthalmic Gel recalled for sterility concerns
FDA (Drugs) · 2025-05-14
- SevereSystane Lubricant Eye Gel Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-05-06